Skip to main content

Advertisement

SpringerLink
Log in

Miliary tuberculosis after infliximab therapy in Lebanon

  • Letter
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abbreviations

PPD:

Purified protein derivative

TNF:

Tumor necrosis factor

References

  1. Blumberg HM, Burman WJ, Chaisson RE et al (2003) American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of tuberculosis. Am J Respir Crit Care Med 67:603–62

    Google Scholar 

  2. Kalaajieh WK (1999) Epidemiology of tuberculosis in Lebanon. Int J Tuberc Lung Dis 3:774–777

    CAS  PubMed  Google Scholar 

  3. Keane J, Gershon S, Wise RP et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098–1104

    CAS  PubMed  Google Scholar 

  4. Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48:2122–2127

    Article  CAS  PubMed  Google Scholar 

  5. Hamilton CD (2003) Tuberculosis in the cytokine era: what rheumatologists need to know. Arthritis Rheum 48:2085–2091

    Article  PubMed  Google Scholar 

  6. Targeted tuberculin testing and treatment of latent tuberculosis infection (2000) This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 161(4 Pt 2):S221–247

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Hamra, 113–6044, 1103 2090, Beirut, Lebanon

    Imad Uthman, Nadim Kanj, Jinane El-Sayad & Abdul-Rahman Bizri

Authors
  1. Imad Uthman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nadim Kanj
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jinane El-Sayad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Abdul-Rahman Bizri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Imad Uthman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uthman, I., Kanj, N., El-Sayad, J. et al. Miliary tuberculosis after infliximab therapy in Lebanon. Clin Rheumatol 23, 279–280 (2004). https://doi.org/10.1007/s10067-004-0873-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-004-0873-z

Keywords

Search

Navigation